Keyphrases
Gene Expression Profiling
100%
Bevacizumab
100%
Retinal pigment Epithelium
100%
Ranibizumab
100%
Anti-VEGF Therapy
100%
VEGF Signaling Pathway
100%
Gene Expression
37%
Endothelial Cells
25%
Rac2
25%
Fab Fragment
25%
NFAT2
25%
NOS3
25%
RPE Cells
25%
Quantitative PCR
12%
Oxidative Stress
12%
Biological Activity
12%
Mode of Action
12%
Signal Transduction
12%
Human Umbilical Vein Endothelial Cells (HUVECs)
12%
Therapeutic Concentrations
12%
Cell Signaling
12%
Age-related Macular Degeneration
12%
Prostaglandin-endoperoxide Synthase 2 (PTGS2)
12%
Transduction Signaling
12%
PIK3CG
12%
PRKCG
12%
Lucentis
12%
EA.hy926
12%
Anti-VEGF Antibody
12%
Neuroscience
Cell Signaling
100%
Vascular Endothelial Growth Factor
100%
Epithelial Cells
100%
Visual Pigment
100%
Ranibizumab
100%
VEGF Signaling
100%
Bevacizumab
88%
Gene Expression
33%
Immunoglobulin F(ab) Fragment
22%
Cell Line
11%
Oxidative Stress
11%
Vasculotropin Antibody
11%
Age-Related Macular Degeneration
11%
Umbilical Vein
11%
PRKCG
11%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Visual Pigment
100%
Ranibizumab
100%
Bevacizumab
88%
Immunoglobulin F(ab) Fragment
22%
Biological Activity
11%
Age Related Macular Degeneration
11%
Vasculotropin Antibody
11%